Here's what happened in pharma and biotech last week πŸ’ŠπŸ“°

The cognition crisis, the biomedical bubble and other interesting reads from the past week.

Noteworthy πŸ“°

Novartis becomes the latest pharma company to give up on antibiotics research. Link

Pfizer plots a major reorganization. Link

Use of β€˜smart drugs’ on the rise. Link

Bankers quit Goldman, Citigroup for biotech riches in Hong Kong. Link

Digital Health πŸ’»

How virtual reality is being used to treat mental health issues. Link

Software beats animal tests at predicting toxicity of chemicals. Link

Research πŸ”¬

Electric shock can deliver genes edited to fight cancer. Link

Dying organs restored to life in novel experiments. Link

Perspective and Opinions πŸ“’

The biomedical bubble? Why UK research and innovation needs a greater diversity of priorities, politics, places, and people. Link

The opioid crisis may be on the decline. Link

Anxiety. Depression. ADHD. Dementia. The human brain is in trouble. Technology is a cause β€” and a solution. Link

Interesting πŸ€”

Dying to survive, a hit Chinese film about patients forced to smuggle cheap generic medicines from India has added to pressure on the country's drug makers to cut costs.